Areas of Expertise
Baxter International Inc. develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide.
Alpha-1 Antitrypsin (AAT) Deficiency
Baxter's pulmonology therapy focuses on patients with alpha-1 antitrypsin deficiency (AATD).
Our long-standing commitment to provide high-quality therapies for people with hemophilia has led to innovations including the first plasma/albumin-free method recombinant Factor VIII therapy, and monoclonal antibody purification and heat treatment processes.
Immune Thrombocytopenic Purpura (ITP)
Baxter provides purified plasma treatments containing antibodies called immunoglobulins that help Immune Thrombocytopenic Purpura (ITP) patients.
Renal therapies: treatments for patients with kidney failure.
Take control with dialysis at home. There are two types of dialysis you can do at home: Peritoneal Dialysis (PD) and Home Hemodialysis (HHD).
In-center hemodialysis is an option for kidney disease patients who choose to get treatment at a dialysis unit in a clinical setting or a hospital, rather than performing dialysis at home
Primary Immune Deficiency (PID)
Baxter provides purified plasma treatments containing antibodies called immunoglobulins that help Primary Immune Deficiency patients fight off infection.
Protein C Deficiency
People who have too little Protein C form too many clots because their blood does not stop clotting. Clots can develop in blood vessels, particularly in the skin, eyes, kidneys, and brain.